Patents by Inventor Gaoshan WU

Gaoshan WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolo-pyrimidine HIV-1 reverse transcriptase inhibitor, preparation method therefor, and uses thereof
    Patent number: 11225491
    Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing thiazolopyrimidine compounds with the general formulas I and II. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: January 18, 2022
    Assignee: SHAN DONG UNIVERSITY
    Inventors: Xinyong Liu, Dongwei Kang, Peng Zhan, Zhao Wang, Gaoshan Wu
  • Five-membered non aromatic ring-pyrimidine HIV-1 reverse transcriptase inhibitor, preparation method therefor, and uses thereof
    Patent number: 11084830
    Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing five-membered non-aromatic pyrimidines compounds with the general formulas I. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: August 10, 2021
    Assignee: SHAN DONG UNIVERSITY
    Inventors: Xinyong Liu, Dongwei Kang, Peng Zhan, Gaoshan Wu, Zhao Wang
  • THIAZOLO-PYRIMIDINE HIV-1 REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USES THEREOF
    Publication number: 20200361959
    Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing thiazolopyrimidine compounds with the general formulas I and II. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.
    Type: Application
    Filed: October 12, 2018
    Publication date: November 19, 2020
    Inventors: Xinyong LIU, Dongwei KANG, Peng ZHAN, Zhao WANG, Gaoshan WU
  • FIVE-MEMBERED NON AROMATIC RING-PYRIMIDINE HIV-1 REVERSE TRANSCRIPTASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USES THEREOF
    Publication number: 20200361954
    Abstract: The present invention belongs to the field of pharmaceutical technology, specifically disclosing five-membered non-aromatic pyrimidines compounds with the general formulas I. Also including theirs polycrystalline and eutectic, prodrugs and derivatives with same biologically functional, methods for their preparation, and compositions containing one or more of these compounds in the drugs application of treatment and prevention of human immunodeficiency virus.
    Type: Application
    Filed: October 12, 2018
    Publication date: November 19, 2020
    Inventors: Xinyong LIU, Dongwei KANG, Peng ZHAN, Gaoshan WU, Zhao WANG